Active Ingredient(s): Atorvastatin Calcium + Ezetimibe
FDA Approved: * May 3, 2013
Pharm Company: * MERCK SHARP DOHME
Category: Cholesterol

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Liptruzet Overview

Ezetimibe/atorvastatin (trade names Liptruzet, Atozet) is a cholesterol lowering combination drug. In the United States, it was approved in May 2013, by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet.[1] It has also been approved to reduce elevated total cholesterol and elevated LDL in patients diagnosed with homozygous familial hypercholesterolemia as ...

Read more Liptruzet Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Liptruzet Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Atorvastatin Calcium + Ezetimibe
  • Tablet: 10mg + 10mg, 20mg + 10mg, 40mg + 10mg, 80mg + 10mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Liptruzet: (4 results)

Sorted by National Drug Code
  • 66582-320 Liptruzet (Atorvastatin 10 mg (As Atorvastatin Calcium 10.34 mg) / Ezetimibe 10 mg) Oral Tablet by Merck Sharp & Dohme Corp.
  • 66582-321 Liptruzet (Atorvastatin 20 mg (As Atorvastatin Calcium 20.68 mg) / Ezetimibe 10 mg) Oral Tablet by Merck Sharp & Dohme Corp.
  • 66582-322 Liptruzet (Atorvastatin 40 mg (As Atorvastatin Calcium 41.37 mg) / Ezetimibe 10 mg) Oral Tablet by Merck Sharp & Dohme Corp.
  • 66582-323 Liptruzet (Atorvastatin 80 mg (As Atorvastatin Calcium 82.73 mg) / Ezetimibe 10 mg) Oral Tablet by Merck Sharp & Dohme Corp.

Drugs with one or more similar ingredients: (7 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 8 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA